Federal Drug Policy Shifts: Insights from Regina LaBelle
Episode Overview
Potential changes in federal drug policy under the new Trump administration. Importance of harm reduction services like syringe programs and naloxone distribution. Impact of cryptocurrency on drug trafficking and money laundering. Balancing public health initiatives with law enforcement efforts. Need for ongoing engagement and bipartisan support in drug policy.
It's not a time to opt out. It's a time to opt in.
In this episode of Scope of Practice, Jeffrey Kwame kicks off Season 6 with an engaging conversation with Regina LaBelle, a distinguished scholar at Georgetown University. Regina brings a wealth of experience from her roles in the Biden-Harris and Obama administrations, where she focused on drug policy and public health. The discussion centres on the potential shifts in federal drug policy under the new Trump administration and what it means for harm reduction services and addiction treatment.
Regina shares insights on how policymakers can balance public health with law enforcement, highlighting the importance of evidence-based practices and compassion in drug policy. She also discusses the role of syringe services programs, naloxone distribution, and the impact of cryptocurrency on drug trafficking. Regina emphasises the need for ongoing engagement and collaboration across political lines to ensure effective drug policy and support for those struggling with addiction.
With her extensive background, Regina offers a unique perspective on the challenges and opportunities in the field. This episode is a must-listen for anyone interested in understanding the complexities of drug policy and its impact on public health.